BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12900763)

  • 1. Gene therapy to target dendritic cells from blood to lymph nodes.
    Robert C; Klein C; Cheng G; Kogan A; Mulligan RC; von Andrian UH; Kupper TS
    Gene Ther; 2003 Aug; 10(17):1479-86. PubMed ID: 12900763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
    Chan T; Sami A; El-Gayed A; Guo X; Xiang J
    Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
    Okada N; Mori N; Koretomo R; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
    Gene Ther; 2005 Jan; 12(2):129-39. PubMed ID: 15483669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of homing receptors and vascular addressins in tonsils and draining lymph nodes: Effect of Brucella infection in sheep.
    Suraud V; Olivier M; Bodier CC; Guilloteau LA
    Vet Immunol Immunopathol; 2007 Feb; 115(3-4):239-50. PubMed ID: 17161868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
    Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
    Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.
    Chinnasamy N; Treisman JS; Oaks MK; Hanson JP; Chinnasamy D
    Gene Ther; 2005 Feb; 12(3):259-71. PubMed ID: 15668698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting dendritic cells for priming cellular immune responses.
    Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
    J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
    Verdijk P; Aarntzen EH; Lesterhuis WJ; Boullart AC; Kok E; van Rossum MM; Strijk S; Eijckeler F; Bonenkamp JJ; Jacobs JF; Blokx W; Vankrieken JH; Joosten I; Boerman OC; Oyen WJ; Adema G; Punt CJ; Figdor CG; de Vries IJ
    Clin Cancer Res; 2009 Apr; 15(7):2531-40. PubMed ID: 19318472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
    Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
    Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent in vivo anti-tumor activity of isolated CD62L(low) lymph node cells sensitized in vivo with tumor lysate-pulsed DC-based vaccines.
    Liu Z; Fan H; Wu Y; Chen B
    Cytotherapy; 2005; 7(4):353-62. PubMed ID: 16162457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.
    Yang J; Huck SP; McHugh RS; Hermans IF; Ronchese F
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):147-52. PubMed ID: 16373503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo.
    Hammerschmidt SI; Ahrendt M; Bode U; Wahl B; Kremmer E; Förster R; Pabst O
    J Exp Med; 2008 Oct; 205(11):2483-90. PubMed ID: 18852290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
    Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
    Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency.
    Yoshikawa T; Niwa T; Mizuguchi H; Okada N; Nakagawa S
    Gene Ther; 2008 Oct; 15(19):1321-9. PubMed ID: 18480845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 production by dendritic cells is not critical for the activation of cognate and innate effectors in draining lymph nodes.
    Schartz NE; Chaput N; Taieb J; Bonnaventure P; Trébeden-Nègre H; Terme M; Ménard C; Lebbé C; Schimpl A; Ardouin P; Zitvogel L
    Eur J Immunol; 2005 Oct; 35(10):2840-50. PubMed ID: 16163668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming.
    Martín-Fontecha A; Baumjohann D; Guarda G; Reboldi A; Hons M; Lanzavecchia A; Sallusto F
    J Exp Med; 2008 Oct; 205(11):2561-74. PubMed ID: 18838544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function.
    Walton KL; He J; Kelsall BL; Sartor RB; Fisher NC
    Immunol Lett; 2006 Jan; 102(1):16-24. PubMed ID: 16105690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm.
    Villadangos JA; Heath WR
    Semin Immunol; 2005 Aug; 17(4):262-72. PubMed ID: 15946854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.